NCT00301275
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Royal Marsden NHS trust Sutton, Surrey, United Kingdom
Clinical trial condition
Multiple Myeloma
Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.
2,641 public trials
502 recruiting studies
Multiple Myeloma trial results
NCT00078065
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Oncotherapeutics Los Angeles, California, United States
- University of California, San Diego San Diego, California, United States
- University of California, San Francisco San Francisco, California, United States
- Johns Hopkins Medical Institute Baltimore, Maryland, United States
Completed
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
NCT00036140
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Research Center Los Angeles, California, United States
- Research Center Los Angeles, California, United States
- Research Center Rancho Mirage, California, United States
- Research Center Cleveland, Ohio, United States
NCT01947140
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +44 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Columbia University Irving Medical Center New York, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
Terminated
Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT04649073
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Tokai University Hospital Isehara-shi, Japan
- Nagoya City University Hospital Nagoya, Japan
- National Hospital Organization Okayama Medical Center Okayama, Japan
- Sapporo Medical University Hospital Sapporo, Japan
NCT06876142
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06572605
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Disease in Multiple Myeloma, +13 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Suspended
Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma
NCT06179888
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT06232044
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Mary Greeley Medical Center Ames, Iowa, United States
- McFarland Clinic - Ames Ames, Iowa, United States
- McFarland Clinic - Boone Boone, Iowa, United States
- McFarland Clinic - Trinity Cancer Center Fort Dodge, Iowa, United States
NCT07102212
- Conditions
- Alzheimer Disease, Anxiety Disorders, Behavior, +56 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States